PubRank

E O Long

Author PubWeight™ 160.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Repeated genes in eukaryotes. Annu Rev Biochem 1980 11.23
2 Essential role of LAT in T cell development. Immunity 1999 3.94
3 Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995 3.72
4 Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996 3.33
5 Nucleotide sequence of the initiation site for ribosomal RNA transcription in Drosophila melanogaster: comparison of genes with and without insertions. Proc Natl Acad Sci U S A 1981 3.21
6 DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 1985 3.20
7 Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995 3.19
8 Expression of ribosomal DNA insertions in Drosophila melanogaster. Cell 1979 3.19
9 Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998 2.79
10 Ribosomal DNA in Drosophila melanogaster. I. Isolation and characterization of cloned fragments. J Mol Biol 1978 2.68
11 Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2001 2.52
12 Structural model of HLA-DR1 restricted T cell antigen recognition. Cell 1988 2.41
13 Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995 2.37
14 A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999 2.36
15 Allelic polymorphism and complexity of the genes for HLA-DR beta-chains--direct analysis by DNA-DNA hybridization. Nature 1982 2.34
16 CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. J Immunol 1988 2.22
17 Isolation of cDNA clones encoding HLA-DR alpha chains. Proc Natl Acad Sci U S A 1982 2.17
18 Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med 1988 2.14
19 HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 1989 2.11
20 Ribosomal insertion-like elements in Drosophila melanogaster are interspersed with mobile sequences. Cell 1981 2.08
21 Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990 2.07
22 Restriction analysis of spacers in ribosomal DNA of Drosophila melanogaster. Nucleic Acids Res 1979 2.04
23 An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med 1990 1.94
24 Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci U S A 1993 1.92
25 The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 1997 1.91
26 Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995 1.85
27 A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 1991 1.84
28 Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 1986 1.82
29 Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay. Proc Natl Acad Sci U S A 1982 1.77
30 The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J 1984 1.72
31 Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001 1.69
32 Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 1996 1.69
33 Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992 1.68
34 Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis. Nature 1986 1.64
35 A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 1997 1.63
36 Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med 1986 1.61
37 Alternative pathways in the processing of ribosomal RNA precursor in Drosophila melanogaster. J Mol Biol 1980 1.59
38 In search of a function for the invariant chain associated with Ia antigens. Surv Immunol Res 1985 1.57
39 A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 1997 1.53
40 Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 1997 1.53
41 Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med 1992 1.52
42 A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996 1.50
43 A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem 1997 1.50
44 Infection of natural killer cells by human herpesvirus 6. Nature 1993 1.47
45 Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line. EMBO J 1982 1.46
46 Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family. Immunogenetics 1984 1.45
47 Expression of the ribosomal DNA insertions in bobbed mutants of Drosophila melanogaster. Mol Gen Genet 1981 1.38
48 The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 1990 1.34
49 Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J 1992 1.33
50 Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry? Immunol Today 1989 1.28
51 Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens. Proc Natl Acad Sci U S A 1983 1.27
52 Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 2000 1.27
53 NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J Immunol 2000 1.26
54 Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol 1997 1.24
55 Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol 1994 1.22
56 Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J Exp Med 1993 1.21
57 Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule. EMBO J 1989 1.20
58 The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling. J Biol Chem 1999 1.16
59 Structure and expression of ribosomal RNA genes of Drosophila melanogaster interrupted by type-2 insertions. Cold Spring Harb Symp Quant Biol 1981 1.15
60 Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. Proc Natl Acad Sci U S A 1996 1.13
61 The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol 1995 1.12
62 Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. J Immunol 1998 1.10
63 Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc Natl Acad Sci U S A 1996 1.09
64 Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J Immunol 1999 1.06
65 Intracellular traffic and antigen processing. Immunol Today 1989 1.05
66 Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes. Nature 1984 1.03
67 Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains. Eur J Immunol 1997 1.03
68 HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur J Immunol 1997 1.02
69 Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today 1996 1.02
70 Recombination within the HLA-D region. Correlation of molecular genotyping with functional data. J Exp Med 1984 1.00
71 Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J Exp Med 1997 0.99
72 New nomenclature for MHC receptors. Nat Immunol 2001 0.99
73 Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc Natl Acad Sci U S A 1992 0.99
74 Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 1998 0.98
75 MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J Immunol 1992 0.98
76 Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. J Neuroimmunol 2005 0.96
77 Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines. J Immunol 1988 0.95
78 Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules. J Exp Med 1990 0.95
79 Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor. J Biol Chem 2000 0.94
80 HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol 1990 0.94
81 Regulation through inhibitory receptors: Lessons from natural killer cells. Trends Cell Biol 1997 0.94
82 Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. Proc Natl Acad Sci U S A 1988 0.94
83 Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 1996 0.93
84 T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. J Neuroimmunol 1997 0.92
85 Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Ann N Y Acad Sci 1988 0.91
86 T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence. J Exp Med 1994 0.91
87 A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer. Eur J Immunol 2000 0.89
88 Molecular analysis of the genes for human class II antigens of the major histocompatibility complex. Hum Immunol 1983 0.88
89 Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J Immunol 1993 0.87
90 Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. J Exp Med 1992 0.86
91 Binding of soluble KIR-Fc fusion proteins to HLA class I. Methods Mol Biol 2000 0.86
92 HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995 0.84
93 Signal sequences stop killer cells. Nature 1998 0.81
94 Exposing tumor cells to killer cell attack. Nat Med 2000 0.80
95 Natural killer cells and mast cells from gp49B null mutant mice are functional. Mol Cell Biol 2000 0.78
96 Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles. J Immunol 1996 0.78
97 Expression patterns of MHC class II genes in rabbit tissues indicate close homology to human counterparts. J Immunol 1987 0.78
98 Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain. J Immunol 1999 0.78
99 Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cells. Scand J Immunol 1991 0.78
100 Transcription of unrearranged T cell receptor delta genes in CD3- major histocompatibility complex-unrestricted cytotoxic cells. Eur J Immunol 1989 0.77
101 An unusual form of alternative splicing in the HLA-DNA gene. Immunogenetics 1991 0.75
102 Structure of a human natural killer cell inhibitory receptor. Transplant Proc 1999 0.75
103 Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts. Hum Immunol 1988 0.75
104 Use of vaccinia virus for functional gene transfer in natural killer cells. Methods Mol Biol 2000 0.75
105 Homogenous expression of killer cell immunoglobulin-like receptors (KIR) on polyclonal natural killer cells detected by a monoclonal antibody to KIR2D. Tissue Antigens 2000 0.75